跳至主要内容
临床试验/IRCT20231209060313N1
IRCT20231209060313N1尚未招募3 期

Therapeutic effect of the regiment of helicobacter pylori treatment on the improvement of pain and symptoms of arthritis in patients with rheumatoid arthritis

Shahre-kord University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Patients with mild to moderate rheumatoid arthritis diagnosed by EULAR criteria (under traditional treatment with DMARD)
  • Willingness to participate in the clinical trial
  • Presence of positive H pylori infection based on endoscopy, fecal antigen or serum antibody test
  • No recent use of antibiotics
  • Absence of immunodeficiency diseases and active cancer
  • Having an indication for the treatment of Helicobacter pylori infection

排除标准

  • The patient's unwillingness to participate in the clinical trial
  • death of the patient
  • Severe rheumatoid arthritis and the use of biological drugs in the treatment of RA
  • Patients with other systemic diseases, who have gastrointestinal surgery, have an active gastric ulcer, or synovectomy in any major joint.

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验